This statistic shows the top 10 drug classes in Canada based on share of total public drug program spending in 2022. In that year, 1.9 percent of total drug program spending was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
CIHI. (November 2, 2023). Leading 10 drug classes by share of total public drug program spending in Canada in 2022 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 26, 2026, from /statistics/441108/share-of-public-drug-program-spending-canada-by-top-drug-classes/
CIHI. "Leading 10 drug classes by share of total public drug program spending in Canada in 2022." Chart. November 2, 2023. ÌÇÐÄÆƽâ°æ. Accessed July 26, 2026. /statistics/441108/share-of-public-drug-program-spending-canada-by-top-drug-classes/
CIHI. (2023). Leading 10 drug classes by share of total public drug program spending in Canada in 2022. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 26, 2026. /statistics/441108/share-of-public-drug-program-spending-canada-by-top-drug-classes/
CIHI. "Leading 10 Drug Classes by Share of Total Public Drug Program Spending in Canada in 2022." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 2 Nov 2023, /statistics/441108/share-of-public-drug-program-spending-canada-by-top-drug-classes/
CIHI, Leading 10 drug classes by share of total public drug program spending in Canada in 2022 ÌÇÐÄÆƽâ°æ, /statistics/441108/share-of-public-drug-program-spending-canada-by-top-drug-classes/ (last visited July 26, 2026)
Leading 10 drug classes by share of total public drug program spending in Canada in 2022 [Graph], CIHI, November 2, 2023. [Online]. Available: /statistics/441108/share-of-public-drug-program-spending-canada-by-top-drug-classes/
